Showing results (11-20 of 416) with videos related to
Sort By:
Pageof 42
Sensors (Basel, Switzerland)|September 20, 2017
Enabling Large-Scale IoT-Based Services through Elastic Publish/SubscribeSergio Vavassori, Javier Soriano, Rafael FernándezNanoscale|April 6, 2019
Selective and fast plasmon-assisted photo-heating of nanomagnetsMatteo Pancaldi, Naëmi Leo, Paolo VavassoriParasites & Vectors|December 14, 2019
Active dispersal of Aedes albopictus: a mark-release-recapture study using self-marking unitsLaura Vavassori, Adam Saddler, Pie MüllerNanophotonics (Berlin, Germany)|December 5, 2024
Terahertz metamaterials for light-driven magnetismMatteo Pancaldi, Paolo Vavassori, Stefano BonettiEuropean Cardiology|March 24, 2022
Circulating MicroRNAs as Novel Biomarkers in Risk Assessment and Prognosis of Coronary Artery DiseaseChiara Vavassori, Eleonora Cipriani, Gualtiero Ivanoe ColomboFrontiers in Cell and Developmental Biology|June 13, 2022
Trained Immunity in Perivascular Adipose Tissue of Abdominal Aortic Aneurysm-A Novel Concept for a Still Elusive DiseaseLuca Piacentini, Chiara Vavassori, Gualtiero I ColomboJournal of Addictions Nursing|March 12, 2015
Parental contributions and separation anxiety on adolescents' cannabis use: a preliminary study based on French high school studentsClaire-Emmanuelle Laguerre, David Vavassori, Lydia FernandezJournal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
A polypyrimidine tract-binding protein-dependent pathway of mRNA stability initiates with CpG activation of primary B cellsJoseph F Porter, Stefano Vavassori, Lori R CoveyTumori|November 22, 2021
Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?Fausto Petrelli, Gianluca Perego, Ivano Vavassori, et al.Frontiers in Pharmacology|August 27, 2024
Unlocking the full potential of rare disease drug development: exploring the not-for-profit sector's contributions to drug development and accessStefano Vavassori, Sean Russell, Celeste Scotti, et al.Pageof 42